September 5, 2017
Third International Cancer Immunotherapy Conference
Vyriad CEO Dr. Stephen Russell presents at the CRI-CIMT-EATI-AACR as plenary speaker.
February 23-25, 2017
ASCO-SITC Clinical Immuno-Oncology Symposium
Stephen J Russell from Vyriad was invited to present on "Viral Therapy" at the ASCO-SITC conference on exploiting viruses for cancer therapy in combination with immune modulators.
October 1-4, 2016
the 10th International Meeting on Replicating Oncolytic Virus Therapeutics
Kah-Whye Peng, PhD, CTO of Vyriad gave a Plenary presentation entitled “Vesicular stomatitis virus (VSV) as an oncolytic agent”
Stephen J. Russell, MD, PhD, CEO & President of Vyriad gave a Plenary presentation entitled “Measles as a versatile oncolytic agent”
June 18, 2016
35th Annual Meeting of the American Society of Virology
Keynote Lecture: “Oncolytic Viruses: Past, Present, and Future”
Stephen J. Russell, MD, PhD, CEO & President, Vyriad